APPLICATION OF SOLID PERORAL DOSING COMPOSITION OF PROLONGED ACTION FOR PREPARING MEDICATIONS Russian patent published in 2011 - IPC A61K9/20 A61K31/137 A61P11/02 A61K31/4545 A61P37/08 

Abstract RU 2423106 C9

FIELD: medicine.

SUBSTANCE: claimed is application of solid peroral dosing composition of prolonged action, which includes (a) core, containing effective amount of pseudoephedrine or its salt, (b) first envelope, covering core and including swelling in water film-forming neutral or cationogenic copolymer ester, film modifier and lubricating substance, and (c) second envelope, covering first envelope and including effective amount of desloratadine, amount of pseudoephedrine or its salt is sufficient for ensuring maximaum of average geometrical values of pseudoephedrine concentration in plasma, from 345 to 365 ng/ml, for the time from 7.60 to 8.40 h, and amount of desloratadine is sufficient for ensuring maximum of its average geometrical values of concentration in plasma, from 2.10 to 2.45 ng/ml, for period from 4.0 to 4.5 h after intake of single dose of said composition, for preparation of medication for treatment of allergic and/or inflammatory states of upper and lower respiratory ways and skin, or urticaria and nasal and non-nasal symptoms of year-round and seasonal allergic rhinitis.

EFFECT: composition ensures necessary profile of active agents release and is efficient in treatment of allergic bronchospasm, couphing, seasonal allergic rhinites.

3 cl, 4 tbl, 4 ex

Similar patents RU2423106C9

Title Year Author Number
STABLE ORAL DOSED SUSTAINED-RELEASE COMPOSITION 2000
  • Kou Dzhim Kh.
RU2303440C2
PERORAL DOSED COMPOSITION OF PROLONGED ACTION 2000
  • Cho Ving-Ki Filip
RU2284182C9
TABLET CONTAINING CETIRIZINE AND PSEUDOEPHEDRINE 2002
  • Fanara Domeniko
  • Gisho Antoni
  • Bervae Monik
  • Deleer Mishel'
RU2286784C2
PHARMACEUTICAL DOSAGE FORMS AND COMPOSITIONS OF COLON ABSORBED PHENYLEPHRINE 2007
  • Montejs Dehjvid
  • O'Mullan Dzhon
  • Reo Dzhozef P.
  • Novak Robert T.
  • Van Dzhiansheng
  • Kabir Mokhammed A.
  • Abutarif Malaz A.
  • Fritts Glenn E.
RU2454225C2
PHARMACEUTICAL COMPOSITIONS CONTAINING CONJUGATED ESTROGENS AND BAZEDOXIFENE 2006
  • Chatlapalli Ramarao S.
  • Nagi Arvinder
  • Van Pel'T Lorens
RU2395286C2
HARD, SUITABLE FOR ORAL INTAKE PHARMACEUTICAL FORMS OF APPLICATION, CONTAINING RIVAROXABAN WITH MODIFIED RELEASE 2005
  • Benke Klaus
  • Khenk Jan-Olav
RU2420290C2
PROLONGED PHARMACEUTICAL COMPOSITION DRUG FORM AND METHOD OF ITS PRODUCTION (VERSIONS) 2009
  • Alekseev Konstantin Viktorovich
  • Alekseev Viktor Konstantinovich
  • Blynskaja Evgenija Viktorovna
  • Jakunina Julija Sergeevna
  • Sheludchenko Ol'Ga Sergeevna
  • Prokhorkov Nikolaj Alekseevich
RU2435584C2
COMPOSITIONS OF ORALLY DISPERSIBLE TABLETS CONTAINING COMBINATIONS OF HIGH- AND LOW-DOSE THERAPEUTIC AGENTS 2010
  • Venkatesh Gopi M.
  • Clevenger James
  • Gosselin Michael
  • Lai Jin-Wang
RU2554740C2
MATRIX TABLET WITH BASIS FOR TRIMETAZIDINE DIHYDROCHLORIDE RELEASE, WAY OF ITS RECEPTION AND WAY OF TREATMENT 2007
  • Kokeladze Merab Revazovich
RU2362548C1
SUGAR COATINGS AND METHODS OF THEIR APPLICATION 2005
  • Klark Dzhon S.
  • Micheluuchchi Dzhon Dzh.
  • Sherman Debora M.
RU2428178C2

RU 2 423 106 C9

Authors

Kou Dzhim Kh.

Dates

2011-07-10Published

2007-02-02Filed